OpGen Inc. Reports 52% Revenue Increase to $5.2 Million in 2024, Driven by Listing Sponsorship Services; Product Sales Decline Significantly

Reuters
08/22
OpGen Inc. Reports 52% Revenue Increase to $5.2 Million in 2024, Driven by Listing Sponsorship Services; Product Sales Decline Significantly

OpGen Inc. has released its annual financial results for the fiscal year ending December 31, 2024. The company reported a shift in its revenue streams following the acquisition by AEI Capital Ltd. and the establishment of CapForce as a wholly-owned subsidiary. Revenue was generated from CapForce's listing sponsorship and consulting services, marking a change from previous years where product sales and laboratory services were the primary sources. The company did not disclose specific figures for net income or losses. However, it indicated that financing arrangements with AEI Capital Ltd. will be pivotal for future operations. OpGen's repositioned business model also reflects a change in cost structure. The cost of sales now primarily includes subcontractor and advisor fees and technology infrastructure costs. Research and development expenses are focused on developing the digital investment banking platform. Looking ahead, OpGen anticipates continued revenue generation from CapForce's services and plans to strategically use financing opportunities to strengthen its financial position. The company is focused on expanding and innovating within its current business framework.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OpGen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-25-006628), on August 21, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10